Tau Capital
Tau Capital, established in 2007 and based in Douglas, United Kingdom, is an investment company focused on the vibrant economy of Kazakhstan and its neighboring countries, including the Kyrgyz Republic, Uzbekistan, Turkmenistan, Tajikistan, Russia, and Mongolia. The firm provides investors with access to a variety of investment opportunities in these regions through a combination of public and private equity, as well as special situations. Tau Capital has a particular interest in sectors such as energy and consumer products and services, positioning itself to capitalize on the potential for growth in these markets.
Pharma73, founded in 2011, specializes in the development of functional excipients through its innovative biopolymer production technology platform that utilizes microbial fermentation. The company focuses on creating natural biopolymer products with unique properties, making them suitable for use as excipients in pharmaceutical, cosmetic, and food industries. By enabling clients to develop and commercialize high functionality excipients, Pharma73 aims to enhance product performance and meet the evolving needs of these sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.